Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins

被引：23

作者：

Abraham, JD

Himoudi, N

Kien, F

Berland, JL

Codran, A

Bartosch, B

Baumert, T

Paranhos-Baccala, G

Schuster, C

Inchauspé, G

Kieny, MP

机构：

[1] INSERM, U544, Inst Virol, F-67000 Strasbourg, France

[2] Ecole Normale Super Lyon, CNRS, UMR 2142, BioMerieux, F-69364 Lyon 07, France

[3] CERVI, CNRS, UMR 2142, BioMerieux, F-69364 Lyon 07, France

[4] Ecole Normale Super Lyon, INSERM, U412, IFR 128, F-69364 Lyon 07, France

[5] Univ Freiburg, Dept Med 2, Freiburg, Germany

来源：

VACCINE | 2004年 / 22卷 / 29-30期

关键词：

HCV; MVA; immunization; humoral and cellular responses;

D O I：

10.1016/j.vaccine.2004.04.005

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We have evaluated in C57[1316 and HLA-A2.1 transgenic mice the immunogenicity of three MVA vectors expressing either native HCV El E2 polyprotein. truncated and secreted El (E'1 (311)) and E2 (E'2(661)) proteins, or a chimeric El E2 heterodimer presented at the plasma membrane. Immunization induced mainly a Th1 response in HLA-A2.1 transgenic mice while a Th2-type response was detected in C57/B16 mice. Comparison of the three vectors shows an increase in the humoral response when antigens are secreted or membrane bound, and slightly in the cellular response when antigens are exposed on the cell surface. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：3917 / 3928

页数：12

共 50 条

[1] Random mutagenesis study of E1 and E2 glycoproteins of hepatitis C virus
Rychlowska, M.
Bienkowska-Szewczyk, K.
Patel, A. H.
JOURNAL OF HEPATOLOGY, 2007, 46 : S167 - S167
[2] Structure-function analysis of hepatitis C virus envelope glycoproteins E1 and E2
Nayak, Aparajita
Pattabiraman, Nagarajan
Fadra, Numrah
Goldman, Radoslav
Pond, Sergei L. Kosakovsky
Mazumder, Raja
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2015, 33 (08): : 1682 - 1694
[3] Production of prostaglandin E2 in response to infection with modified vaccinia Ankara virus
Pollara, Justin J.
Spesock, April H.
Pickup, David J.
Laster, Scott M.
Petty, Ian T. D.
VIROLOGY, 2012, 428 (02) : 146 - 155
[4] Immunological Characterization of a Modified Vaccinia Virus Ankara Vector Expressing the Human Papillomavirus 16 E1 Protein
Remy-Ziller, Christelle
Germain, Claire
Spindler, Anita
Hoffmann, Chantal
Silvestre, Nathalie
Rooke, Ronald
Bonnefoy, Jean-Yves
Preville, Xavier
CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (02) : 147 - 155
[5] Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins
Drummer, HE
Maerz, A
Poumbourios, P
FEBS LETTERS, 2003, 546 (2-3): : 385 - 390
[6] Incorporation of Hepatitis C Virus E1 and E2 Glycoproteins: The Keystones on a Peculiar Virion
Vieyres, Gabrielle
Dubuisson, Jean
Pietschmann, Thomas
VIRUSES-BASEL, 2014, 6 (03): : 1149 - 1187
[7] The membrane-active regions of the hepatitis C virus E1 and E2 envelope glycoproteins
Pérez-Berná, AJ
Moreno, MR
Guillén, J
Bernabeu, A
Villalaín, J
BIOCHEMISTRY, 2006, 45 (11) : 3755 - 3768
[8] Immunogenicity of highly conserved fragments of hepatitis C virus envelop proteins E1 and E2
Kuraeva, Tatiana E.
Olenina, Ludmila V.
Kuzmina, Tatiana I.
Alyoshina, Elena Yu.
Kolesanova, Ekaterina F.
Archakov, Alexander I.
PEPTIDES 2004, PROCEEDINGS: BRIDGES BETWEEN DISCIPLINES, 2005, : 21 - 22
[9] IMMUNOGENICITY OF HIGHLY CONSERVED FRAGMENTS OF HEPATITIS C VIRUS ENVELOPE PROTEINS E1 AND E2
Kuraeva, T. E.
Olenina, L. V.
Kuzmina, T. I.
Alyoshina, E. Y. U.
Kolesanova, E. K.
Archakov, A. I.
JOURNAL OF PEPTIDE SCIENCE, 2004, 10 : 96 - 96
[10] Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity
Patra, Tapas
Meyer, Keith
Haga, Yuki
Reagan, Erin K. K.
Weissman, Drew
Ray, Ranjit
NPJ VACCINES, 2023, 8 (01)

← 1 2 3 4 5 →